<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00685984</url>
  </required_header>
  <id_info>
    <org_study_id>P070403</org_study_id>
    <nct_id>NCT00685984</nct_id>
  </id_info>
  <brief_title>Peripheral Endothelial Function and Coronary Status in Asymptomatic Diabetic Patients</brief_title>
  <acronym>PEFDIA</acronym>
  <official_title>Peripheral Endothelial Function and Coronary Status in Asymptomatic Type 2 Diabetic Patients: Relations With Coronary Microcirculation Assessed With Trans-thoracic Echo-doppler</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alfediam</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Silent myocardial ischemia is usual in type 2 diabetic patients and associated with coronary
      stenoses and endothelial dysfunction or both. We therefore hypothesized that peripheral
      endothelial dysfunction is a marker of silent myocardial ischemia. The aim of the study is,
      in 120 asymptomatic type 2 diabetic patients, to evaluate the relations between coronary
      status, assessed with myocardial scintigraphy and subsequent coronary angiography in case of
      abnormality, and peripheral endothelial function, according to post-occlusive hyperaemia
      endothelium-dependent brachial artery dilation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Coronary microcirculation, non invasively assessed with trans-thoracic echo-doppler (coronary
      blood flow before and after cold pressure testing), and biochemical markers of endothelial
      dysfunction will also be measured. Correlations between peripheral and coronary endothelial
      functions will be checked. The measurements will be performed and validated in two other
      groups

        -  30 patients with overweight but free of diabetes, matched with the patients with
           diabetes for age, gender and body mass index

        -  30 control subjects.Reproducibility of the methods will be assessed in 10 patients of
           the three groups of subjects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Post-occlusive hyperaemia endothelium-dependent brachial artery dilation</measure>
    <time_frame>immediate</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>noninvasive coronary microcirculation assessed with transthoracic ECHODOPPLER</measure>
    <time_frame>immediate</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cardiac autonomic neuropathy</measure>
    <time_frame>immediate</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cardiac transthoracic echography</measure>
    <time_frame>immediate</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>biologic markers of endothelial function</measure>
    <time_frame>immediate</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">173</enrollment>
  <condition>Myocardial Ischemia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        -  type 2 diabetes

          -  overweight free of diabetes

          -  control
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria :

        FOR TYPE 2 DIABETIC PATIENTS Asymptomatic:

          -  with normal resting ECG

          -  coronary primary prevention

          -  other cardiovascular risk factors justifying screening for silent myocardial ischemia
             and coronary stenoses in case of silent myocardial ischemia.

        FOR PATIENTS WITH OVERWEIGHT:

          -  Asymptomatic with normal resting ECG

          -  coronary primary prevention

          -  Body mass index 25-40 kg/m²

          -  Without diabetes.

        CONTROLS Asymptomatic:

          -  coronary primary prevention

          -  Body mass index 18-25 kg/m²

          -  Without diabetes

          -  Without cardiovascular risk factors including dyslipidemia, hypertension, smoking
             habits, No treatment

        Exclusion criteria :

          -  pregnancy

          -  renal failure

          -  acrosyndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emmanuel COSSON, MD phD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Jean Verdier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Jean Verdier Service of Endocrinologie-Diabétologie-Nutrition</name>
      <address>
        <city>Bondy</city>
        <zip>93140</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Cosson E, Pham I, Valensi P, Pariès J, Attali JR, Nitenberg A. Impaired coronary endothelium-dependent vasodilation is associated with microalbuminuria in patients with type 2 diabetes and angiographically normal coronary arteries. Diabetes Care. 2006 Jan;29(1):107-12.</citation>
    <PMID>16373905</PMID>
  </results_reference>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 26, 2008</study_first_submitted>
  <study_first_submitted_qc>May 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2008</study_first_posted>
  <last_update_submitted>October 27, 2011</last_update_submitted>
  <last_update_submitted_qc>October 27, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 28, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Type 2 diabetes</keyword>
  <keyword>silent myocardial ischemia</keyword>
  <keyword>endothelial function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

